The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Structure and Stability Changes of Human IgG1 Fc as a Consequence of Methionine Oxidation
Abstract
The Fc region has two highly conserved methionine residues, Met 33 (C(H)3 domain) and Met 209 (C(H)3 domain), which are important for the Fc's structure and biological function. To understand the effect of methionine oxidation on the structure and stability of the human IgG1 Fc expressed in Escherichia coli, we have characterized the fully oxidized Fc using biophysical (DSC, CD, and NMR) and bioanalytical (SEC and RP-HPLC-MS) methods. Methionine oxidation resulted in a detectable secondary and tertiary structural alteration measured by circular dichroism. This is further supported by the NMR data. The HSQC spectral changes indicate the structures of both C(H)2 and C(H)3 domains are affected by methionine oxidation. The melting temperature (Tm) of the C(H)2 domain of the human IgG1 Fc was significantly reduced upon methionine oxidation, while the melting temperature of the C(H)3 domain was only affected slightly. The change in the C(H)2 domain T m depended on the extent of oxidation of both Met 33 and Met 209. This was confirmed by DSC analysis of methionine-oxidized samples of two site specific methionine mutants. When incubated at 45 degrees C, the oxidized Fc exhibited an increased aggregation rate. In addition, the oxidized Fc displayed an increased deamidation (at pH 7.4) rate at the Asn 67 and Asn 96 sites, both located on the C(H)2 domain, while the deamidation rates of the other residues were not affected. The methionine oxidation resulted in changes in the structure and stability of the Fc, which are primarily localized to the C(H)2 domain. These changes can impact the Fc's physical and covalent stability and potentially its biological functions; therefore, it is critical to monitor and control methionine oxidation during manufacturing and storage of protein therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Techniques in Protein Chemistry
(1993) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(93)80012-n · Cited by 1,298
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Using NMRView to Visualize and Analyze the NMR Spectra of Macromolecules
Johnson, B. A. (2004) · Protein NMR Techniques · doi:10.1385/1-59259-809-9:313 · Cited by 1,027
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design
Saphire, E. O., Parren, P. W. H. I., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., & Wilson, I. A. (2001) · Science · doi:10.1126/science.1061692 · Cited by 942
Krapp, S., Mimura, Y., Jefferis, R., Huber, R., & Sondermann, P. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01250-0 · Cited by 674
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Computation and Analysis of Protein Circular Dichroism Spectra
Sreerama, N., & Woody, R. W. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)83013-1 · Cited by 525
Multiple Roles for the Major Histocompatibility Complex Class I– Related Receptor FcRn
Ghetie, V., & Ward, E. S. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.739 · Cited by 474
Crystal structure of the complex of rat neonatal Fc receptor with Fc
Burmeister, W. P., Huber, A. H., & Bjorkman, P. J. (1994) · Nature · doi:10.1038/372379a0 · Cited by 431
Crystal structure of the complex of rat neonatal Fc receptor with Fc
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90005-5 · Cited by 381
Sauer-Eriksson, A. E., Kleywegt, G. J., Uhlén, M., & Jones, T. A. (1995) · Structure · doi:10.1016/s0969-2126(01)00157-5 · Cited by 372
Schöneich, C. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.09.009 · Cited by 372
Jefferis, R., Lund, J., & Pound, J. D. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01188.x · Cited by 329
Raghavan, M., Bonagura, V. R., Morrison, S. L., & Bjorkman, P. J. (1995) · Biochemistry · doi:10.1021/bi00045a005 · Cited by 317
Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand
WANG, B., NICHOL, J., & SULLIVAN, J. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.010 · Cited by 295
Contributions of tryptophan side chains to the far-ultraviolet circular dichroism of proteins
Woody, R. W. (1994) · European Biophysics Journal · doi:10.1007/bf00213575 · Cited by 274
Human Antibody Effector Function
Burton, D. R., & Woof, J. M. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60486-1 · Cited by 265
Chelius, D., Rehder, D. S., & Bondarenko, P. V. (2005) · Analytical Chemistry · doi:10.1021/ac050672d · Cited by 263
Antioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2
Lam, X. M., Yang, J. Y., & Cleland, J. L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970143s · Cited by 263
Structure‐dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides
Robinson, N. E., Robinson, Z. W., Robinson, B. R., Robinson, A. L., Robinson, J. A., Robinson, M. L., & Robinson, A. B. (2004) · The Journal of Peptide Research · doi:10.1111/j.1399-3011.2004.00151.x · Cited by 230
Corper, A. L., Sohi, M. K., Bonagura, V. R., Steinitz, M., Jefferis, R., Feinstein, A., Beale, D., Taussig, M. J., & Sutton, B. J. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0597-374 · Cited by 224
Yamaguchi, Y., Nishimura, M., Nagano, M., Yagi, H., Sasakawa, H., Uchida, K., Shitara, K., & Kato, K. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.10.002 · Cited by 204
Chumsae, C., Gaza-Bulseco, G., Sun, J., & Liu, H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.11.050 · Cited by 191
Sreerama, N., Manning, M. C., Powers, M. E., Zhang, J.-X., Goldenberg, D. P., & Woody, R. W. (1999) · Biochemistry · doi:10.1021/bi990516z · Cited by 167
Methionine oxidation as a major cause of the functional impairment of oxidized actin
Dalle‐Donne, I., Rossi, R., Giustarini, D., Gagliano, N., Simplicio, P. D., Colombo, R., & Milzani, A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00799-2 · Cited by 137
Ghirlando, R., Lund, J., Goodall, M. D., & Jefferis, R. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00029-2 · Cited by 107
Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody
Liu, H., Gaza‐Bulseco, G., Tao, X., & Chumsae, C. M. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.07.012 · Cited by 91
Investigation of the Cooperative Structure of Fc Fragments from Myeloma Immunoglobulin G
Tischenko, V. M., Abramov, V. M., & Zav'yalov, V. P. (1998) · Biochemistry · doi:10.1021/bi972647a · Cited by 86
Bartlett, R. K., Urbauer, R. J. B., Anbanandam, A., Smallwood, H. S., Urbauer, J. L., & Squier, T. C. (2003) · Biochemistry · doi:10.1021/bi026956z · Cited by 82
Lu, H. S., Fausset, P. R., Narhi, L. O., Horan, T. P., Shinagawa, K., Shimamoto, G. T., & Boone, T. C. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1022 · Cited by 73
Chu, J., Yin, J., Wang, D. I. C., et al. (2004) · Biochemistry · doi:10.1021/bi0356000 · Cited by 51
Oxidation of Methionine Residues in Coagulation Factor VIIa
Kornfelt, T., Persson, E., & Palm, L. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1071 · Cited by 41
Sigalov, A. B., & Stern, L. J. (2001) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(01)00186-4 · Cited by 38
Quantitative methods for developing Fc mutants with extended half‐lives
Kamei, D. T., Lao, B. J., Speed, M. A., Deshpande, R. R., Xu, H., Tidor, B., & Lauffenburger, D. A. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20624 · Cited by 28
Chugha, P., Sage, H. J., & Oas, T. G. (2006) · Protein Science · doi:10.1110/ps.051856406 · Cited by 26
Vinci, F., Catharino, S., Frey, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311480200 · Cited by 10
Cited by
Protein aggregation: Pathways, induction factors and analysis
Mahler, H.-C., Friess, W., Grauschopf, U., & Kiese, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21566 · Cited by 901
Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
Houde, D., Peng, Y., Berkowitz, S. A., & Engen, J. R. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900540-mcp200 · Cited by 393
Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies
Du, Y., Walsh, A., Ehrick, R., Xu, W., May, K., & Liu, H. (2012) · mAbs · doi:10.4161/mabs.21328 · Cited by 291
Structure, heterogeneity and developability assessment of therapeutic antibodies
Xu, Y., Wang, D., Mason, B., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., et al. (2019) · mAbs · doi:10.1080/19420862.2018.1553476 · Cited by 264
Self-citationEon‐Duval, A., Broly, H., & Gleixner, R. (2012) · Biotechnology Progress · doi:10.1002/btpr.1548 · Cited by 234
Metadata
- Authors
- Liu, D., Ren, D., Huang, H., Dankberg, J., Rosenfeld, R., Cocco, M. J., Li, L., Brems, D. N., & Remmele, R. L.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-04-12
- Volume
- 47
- Issue
- 18
- Pages
- 5088-5100
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2071425823
- Cited by
- 261
- References
- 40
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.